Literature DB >> 9677171

A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda.

M J Wawer1, R H Gray, N K Sewankambo, D Serwadda, L Paxton, S Berkley, D McNairn, F Wabwire-Mangen, C Li, F Nalugoda, N Kiwanuka, T Lutalo, R Brookmeyer, R Kelly, T C Quinn.   

Abstract

OBJECTIVE: To describe the design and first-round survey results of a trial of intensive sexually transmitted disease (STD) control to reduce HIV-1 incidence. STUDY
DESIGN: Randomized, controlled, community-based trial in Rakai District, Uganda.
METHODS: In this ongoing study, 56 communities were grouped into 10 clusters designed to encompass social/sexual networks; clusters within blocks were randomly assigned to the intervention or control arm. Every 10 months, all consenting resident adults aged 15-59 years are visited in the home for interview and sample collection (serological sample, urine, and, in the case of women, self-administered vaginal swabs). Sera are tested for HIV-1, syphilis, gonorrhea, chlamydia, trichomonas and bacterial vaginosis. Following interview, all consenting adults are offered directly observed, single oral dose treatment (STD treatment in the intervention arm, anthelminthic and iron-folate in the control arm). Treatment is administered irrespective of symptoms or laboratory testing (mass treatment strategy). Both arms receive identical health education, condom and serological counseling services.
RESULTS: In the first home visit round, the study enrolled 5834 intervention and 5784 control arm subjects. Compliance with interview, sample collection and treatment was high in both arms (over 90%). Study arm populations were comparable with respect to sociodemographic and behavioral characteristics, and baseline HIV and STD rates. The latter were high: 16.9% of all subjects were HIV-positive, 10.0% had syphilis, and 23.8% of women had trichomonas and 50.9% had bacterial vaginosis.
CONCLUSIONS: Testing the effects of STD control on AIDS prevention is feasible in this Ugandan setting.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--prevention and control; Africa; Africa South Of The Sahara; Comparative Studies; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Hiv Infections--prevention and control; Infections; Measurement; Prevalence; Reproductive Tract Infections; Research Methodology; Research Report; Sexually Transmitted Diseases--prevention and control; Studies; Study Design; Treatment; Uganda; Viral Diseases

Mesh:

Substances:

Year:  1998        PMID: 9677171     DOI: 10.1097/00002030-199810000-00014

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  99 in total

1.  Syphilis control during pregnancy: effectiveness and sustainability of a decentralized program.

Authors:  K Fonck; P Claeys; F Bashir; J Bwayo; L Fransen; M Temmerman
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

2.  Acceptability of a self-sampling technique to collect vaginal smears for gram stain diagnosis of bacterial vaginosis.

Authors:  Elizabeth R Boskey; Shelly A Atherly-Trim; Patricia J O'Campo; Donna M Strobino; Dawn P Misra; P Misra
Journal:  Womens Health Issues       Date:  2004 Jan-Feb

3.  Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity.

Authors:  Matthew M Cousins; San-San Ou; Maria J Wawer; Supriya Munshaw; David Swan; Craig A Magaret; Caroline E Mullis; David Serwadda; Stephen F Porcella; Ronald H Gray; Thomas C Quinn; Deborah Donnell; Susan H Eshleman; Andrew D Redd
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

4.  Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002.

Authors:  Samantha A Conroy; Oliver Laeyendecker; Andrew D Redd; Aleisha Collinson-Streng; Xiangrong Kong; Fredrick Makumbi; Tom Lutalo; Nelson Sewankambo; Noah Kiwanuka; Ronald H Gray; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-06       Impact factor: 2.205

5.  Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda.

Authors:  Chelsea B Polis; Maria J Wawer; Noah Kiwanuka; Oliver Laeyendecker; Joseph Kagaayi; Tom Lutalo; Fred Nalugoda; Godfrey Kigozi; David Serwadda; Ronald H Gray
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

6.  Process evaluation of the SHARE intervention for preventing intimate partner violence and HIV infection in Rakai, Uganda.

Authors:  Jennifer A Wagman; Ronald H Gray; Neema Nakyanjo; Katherine A McClendon; Erika Bonnevie; Fredinah Namatovu; Grace Kigozi; Joseph Kagaayi; Maria J Wawer; Fred Nalugoda
Journal:  Eval Program Plann       Date:  2017-12-24

7.  Impact of Availability and Use of ART/PMTCT Services on Fertility Desires of Previously Pregnant Women in Rakai, Uganda: A Retrospective Cohort Study.

Authors:  Lindsay E Litwin; Frederick E Makumbi; Ronald Gray; Maria Wawer; Godfrey Kigozi; Joseph Kagaayi; Gertrude Nakigozi; Tom Lutalo; David Serwada; Heena Brahmbhatt
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

Review 8.  Antiretrovirals and safer conception for HIV-serodiscordant couples.

Authors:  Lynn T Matthews; Jennifer A Smit; Susan Cu-Uvin; Deborah Cohan
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

9.  Selection of HIV variants with signature genotypic characteristics during heterosexual transmission.

Authors:  Manish Sagar; Oliver Laeyendecker; Sandra Lee; Jordyn Gamiel; Maria J Wawer; Ronald H Gray; David Serwadda; Nelson K Sewankambo; James C Shepherd; Jonathan Toma; Wei Huang; Thomas C Quinn
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

10.  Intimate partner violence as a predictor of marital disruption in rural Rakai, Uganda: a longitudinal study.

Authors:  Jennifer A Wagman; Blake Charvat; Marie E Thoma; Anthony Ndyanabo; Fred Nalugoda; Joseph Ssekasanvu; Grace Kigozi; David Serwadda; Joseph Kagaayi; Maria J Wawer; Ronald H Gray
Journal:  Int J Public Health       Date:  2016-09-13       Impact factor: 3.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.